Liver Cancer: Risk factors, diagnoses, and new treatment options
While liver cancer doesn’t get as much public attention as other forms of cancer, it is a major public health concern. The number of new cases of this kind of cancer has been skyrocketing in recent years; it’s grown by about 115 percent during the past decade.
Hepatologist Dr. Catherine Frenette from the Scripps Clinic joined Lauren Phinney in studio to discuss the latest advances in liver cancer treatment.
This August, the FDA approved a drug called Lenvatinib (marketed as Lenvima) – in clinical trials, this drug showed significant response rate (shrinkage) of tumors (in the range of 25 to 40%).
Catherine is a widely respected hepatology specialist with a national reputation for excellence. She is dedicated to providing comprehensive, compassionate care to patients who have liver disease or liver disorders, including cirrhosis, hepatitis and liver cancer.